Paper Details

  1. Home
  2. Paper Details

A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.

Author: CahillShawn, CampeasRaphael, FoaEdna B, FranklinMartin, HahnChang-Gyu, HembreeElizabeth, HuppertJonathan D, LedleyDeborah Roth, LiebowitzMichael R, PetkovaEva, SchmidtAndrew B, SimpsonHelen Blair, VermesDonna

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

While serotonin reuptake inhibitors (SRIs) are approved to treat obsessive-compulsive disorder (OCD), many people with OCD who have tried SRIs still have significant symptoms. This study examines the effects of adding exposure and ritual prevention, a type of cognitive-behavioral therapy (CBT) for OCD, to SRI treatment.
Paper Details　
Original Abstract of the Article :
Although serotonin reuptake inhibitors (SRIs) are approved for the treatment of obsessive-compulsive disorder (OCD), most OCD patients who have received an adequate SRI trial continue to have clinically significant OCD symptoms. The purpose of this study was to examine the effects of augmenting SRIs...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/18316422

データ提供：米国国立医学図書館（NLM）

Tackling OCD: A Combined Approach

This study delves into the complex world of obsessive-compulsive disorder (OCD), exploring ways to improve treatment outcomes for those struggling with this condition. It focuses on the potential benefits of combining pharmacotherapy (medication) with cognitive-behavioral therapy (CBT), a proven approach for addressing OCD symptoms. The researchers sought to understand whether augmenting serotonin reuptake inhibitors (SRIs), commonly used for OCD treatment, with exposure and ritual prevention (ERP), a core element of CBT, could lead to more significant symptom reduction.

A Synergistic Approach: Unlocking Greater Relief

The results of this study indicate that combining SRIs with ERP can be an effective strategy for reducing OCD symptoms. This approach is like using a combination of tools to clear a path through a desert – one tool might offer limited progress, but together, they can create a more efficient and effective solution. The combined approach may offer more comprehensive symptom relief and improve long-term outcomes for patients with OCD.

Hope and Healing: A Pathway Through the Desert

This research offers hope for individuals struggling with OCD. It suggests that a combined approach, using both medication and therapy, can lead to greater symptom reduction and improved quality of life. It's like finding a hidden oasis in the desert, offering respite and support for those navigating the challenges of OCD.

Dr. Camel's Conclusion

This study offers a promising approach to treating OCD by combining medication with cognitive-behavioral therapy. It's a journey toward greater relief, offering hope and a path toward healing for those struggling with this challenging condition.

Date :
  1. Date Completed 2008-06-10
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

18316422

DOI: Digital Object Identifier

NIHMS556090

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.